Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia ; volume:23 ; number:1 ; day:19 ; month:5 ; year:2023 ; pages:1-18 ; date:12.2023
Cancer cell international ; 23, Heft 1 (19.5.2023), 1-18, 12.2023

Creator: Cuesta-Casanovas, Laia
Delgado-Martínez, Jennifer
Cornet-Masana, Josep M.
Carbó, José M.
Banús-Mulet, Antònia
Guijarro, Francesca
Esteve, Jordi
Risueño, Ruth M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12935-023-02944-4

URN: urn:nbn:de:101:1-2023090911514832881414

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cuesta-Casanovas, Laia
Delgado-Martínez, Jennifer
Cornet-Masana, Josep M.
Carbó, José M.
Banús-Mulet, Antònia
Guijarro, Francesca
Esteve, Jordi
Risueño, Ruth M.
SpringerLink (Online service)

Other Objects (12)

Prolactin Reduces Hippocampal Parvalbumin and GABA A Receptor Expression in Female Mice

The microRNA signature of chemoresistance in acute myeloid leukemia

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro

Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms

Grass Carp Prolactin Gene: Structural Characterization and Signal Transduction for PACAP-induced Prolactin Promoter Activity

Prolactin Reduces Hippocampal Parvalbumin and GABA A Receptor Expression in Female Mice

The microRNA signature of chemoresistance in acute myeloid leukemia

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro

Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms

Grass Carp Prolactin Gene: Structural Characterization and Signal Transduction for PACAP-induced Prolactin Promoter Activity

Prolactin Reduces Hippocampal Parvalbumin and GABA A Receptor Expression in Female Mice

The microRNA signature of chemoresistance in acute myeloid leukemia

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro

Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms

Grass Carp Prolactin Gene: Structural Characterization and Signal Transduction for PACAP-induced Prolactin Promoter Activity

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Prolactin Reduces Hippocampal Parvalbumin and GABA A Receptor Expression in Female Mice

The microRNA signature of chemoresistance in acute myeloid leukemia

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro

Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms

Grass Carp Prolactin Gene: Structural Characterization and Signal Transduction for PACAP-induced Prolactin Promoter Activity

Prolactin Reduces Hippocampal Parvalbumin and GABA A Receptor Expression in Female Mice

The microRNA signature of chemoresistance in acute myeloid leukemia

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro

Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms

Grass Carp Prolactin Gene: Structural Characterization and Signal Transduction for PACAP-induced Prolactin Promoter Activity

Prolactin Reduces Hippocampal Parvalbumin and GABA A Receptor Expression in Female Mice

The microRNA signature of chemoresistance in acute myeloid leukemia

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro

Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms

Grass Carp Prolactin Gene: Structural Characterization and Signal Transduction for PACAP-induced Prolactin Promoter Activity

Related objects

Reset password